Johnson & Johnson’s commitment to investing $55 billion in U.S. manufacturing, research, and development over the next four years marks a significant expansion for the renowned pharmaceutical company. Announced by CEO Joaquin Duato on March 21, this ambitious initiative is intended to bolster the
23andMe’s weekend bankruptcy filing has ignited concerns among consumers who provided the company with their genetic information and reignited discussions on data privacy among policymakers and security experts. Among the genetic testing company’s assets is the genetic information of more than 15
Cuts in federal funding can have profound effects on various sectors, and the medical research community is no exception. Recently, academic medical centers have raised significant concerns over the potential reductions in funding for medical research by the National Institutes of Health (NIH).
The healthcare sector in the United States is facing a mounting crisis due to severe labor shortages. This predicament is leaving millions, especially in rural areas, without adequate access to medical care. Modernizing immigration policies presents a promising solution to bridge the gap in the
MedPAC's annual recommendations to Congress can significantly influence Medicare payment rates and the overall healthcare landscape. Their 2026 proposals, designed to address the escalating costs of healthcare provision, have sparked a lively debate among provider groups. MedPAC's Baseline
Donald Trump's proposed funding cuts to the National Institutes of Health (NIH) could have deep and far-reaching implications for medical research and innovation. These potential reductions in funds have alarmed researchers and scientists who depend heavily on NIH grants to pursue groundbreaking
